Literature DB >> 22740059

Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy.

Dezső Tóth1, Miklós Török, Zsolt Kincses, László Damjanovich.   

Abstract

BACKGROUND: Stage-adapted surgery guarantees the best outcome for patients with gastric cancer. Successful identification of lymph node involvement may help to reduce the number of extended lymphadenectomies. Preoperative diagnostic tools have low sensitivity and specificity for determining lymph node involvement. Evaluation of sentinel lymph nodes (SLNs) intraoperatively has good results, while the accuracy of the Maruyama computer program (MCP) is controversial.
METHODS: We investigated 40 patients by the Maruyama computer model and labeled lymph nodes with blue dye for SLN mapping. To compare the probability calculations by MCP and the results of SLN mapping, we had to define a cutoff level; we did this using receiver-operating characteristics analysis. Sentinel lymph nodes were examined in frozen sections intraoperatively and by standard hematoxylin and eosin staining postoperatively.
RESULTS: A total of 795 lymph nodes were removed and examined. The Maruyama computer model had a sensitivity of 91.3 %, specificity of 64 %, and accuracy of 80 % by the best cutoff point. The false-negative rate was 8.7 %. The sensitivity of SLN mapping was 95.7 %, the false-negative rate was 4.3 %, and the specificity was 100 %. The accuracy of SLN mapping was 97.4 %. Only the sensitivity of MCP and SLN biopsy was proven equivalent.
CONCLUSIONS: Our results suggest that intraoperative SLN examination is superior to preoperative estimation with the MCP. Correct definition of lymph node involvement helps in planning the best stage-adapted surgery in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740059     DOI: 10.1007/s10120-012-0170-5

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  21 in total

Review 1.  Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis.

Authors:  Zhen Wang; Zhi-Yong Dong; Jun-Qiang Chen; Jin-Lu Liu
Journal:  Ann Surg Oncol       Date:  2011-11-03       Impact factor: 5.344

2.  Lymph node metastases of gastric cancer. General pattern in 1931 patients.

Authors:  K Maruyama; P Gunvén; K Okabayashi; M Sasako; T Kinoshita
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

3.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

Review 4.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

5.  Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer.

Authors:  S Guadagni; G de Manzoni; M Catarci; M Valenti; G Amicucci; G De Bernardinis; C Cordiano; M Carboni; K Maruyama
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

6.  Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program.

Authors:  E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert
Journal:  Br J Surg       Date:  1992-02       Impact factor: 6.939

7.  Value of sentinel lymph node mapping using a blue dye-only method in gastric cancer: a single-center experience from North-East Hungary.

Authors:  Dezso Tóth; Zsolt Kincses; János Plósz; Miklós Török; Ilona Kovács; Csongor Kiss; László Damjanovich
Journal:  Gastric Cancer       Date:  2011-05-03       Impact factor: 7.370

8.  Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients.

Authors:  G H Kampschöer; K Maruyama; C J van de Velde; M Sasako; T Kinoshita; K Okabayashi
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

9.  Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study.

Authors:  Elfriede H Bollschweiler; Stefan P Mönig; Karin Hensler; Stephan E Baldus; Keiichi Maruyama; Arnulf H Hölscher
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  5 in total

Review 1.  Do all the European surgeons perform the same D2? The need of D2 audit in Europe.

Authors:  Maria Bencivenga; Giuseppe Verlato; Valentina Mengardo; Jacopo Weindelmayer; William H Allum
Journal:  Updates Surg       Date:  2018-06-04

Review 2.  Clinical significance of lymphadenectomy in patients with gastric cancer.

Authors:  Dezső Tóth; János Plósz; Miklós Török
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

3.  The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System.

Authors:  Sung Hwan Hwang; Hyun Il Kim; Jun Seong Song; Min Hong Lee; Sung Joon Kwon; Min Gyu Kim
Journal:  J Gastric Cancer       Date:  2016-12-20       Impact factor: 3.720

4.  Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection.

Authors:  Bin Ke; Xi-Na Song; Ning Liu; Ru-Peng Zhang; Chang-Li Wang; Han Liang
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

5.  Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer.

Authors:  Rui Zhou; Zhenzhen Wu; Jingwen Zhang; Hongqiang Wang; Yuqi Su; Na Huang; Min Shi; Jianping Bin; Yulin Liao; Wangjun Liao
Journal:  Oncotarget       Date:  2016-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.